Fig. 2From: Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cmEQD2 ≥74 Gy was a significant prognostic factor. a OS; b DMFS; c LRFS; d PFSBack to article page
